CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that ...
The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.
What would the impact on CVS Health, Cigna, and UnitedHealth Group be if she's wrong? Although PBMs aren't the only moneymaker for CVS Health, Cigna, and UnitedHealth Group, they're important ...
FTC’s lawsuit against PBMs puts UnitedHealth, CVS, and Cigna stocks in focus for investors seeking stability. Cigna could see more price movement than UNH and CVS, thanks to its focused business ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback